All In MedTech

FDA Clearance Tracker · P160026

LIFEPAK 1000 DEFIBRILLATOR, LIFEPAK 20 DEFIBRILLATOR/ MONITOR, LIFEPAK 20E DEFIBRILLATOR/ MONITOR, LIFEPAK 15 MONITOR/DE

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Jul 2, 2018 (this decision)Source: openFDAMethods & limitations

PMA

The decision

FDA number
P160026
Device name
LIFEPAK 1000 DEFIBRILLATOR, LIFEPAK 20 DEFIBRILLATOR/ MONITOR, LIFEPAK 20E DEFIBRILLATOR/ MONITOR, LIFEPAK 15 MONITOR/DE
Applicant location
Redmond, WA
Received
Jul 25, 2016
Decided
Jul 2, 2018
Decision
Approved
Supplements
72 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Regulation
21 CFR 870.5310

Every decision under product code MKJ

FDA's approval statement

As written in FDA's record.

Approval for the LIFEPAK® 1000 Defibrillator, LIFEPAK® 1000 Defibrillator Lithium-ion Rechargeable Battery, LIFEPAK® 20 Defibrillator/ Monitor (Refurbished), LIFEPAK® 20e Defibrillator/ Monitor, LIFEPAK® 15 Monitor/Defibrillator, and LIFEPAK® Lithium-ion Rechargeable Battery (for use with the LIFEPAK® 15 Monitor/Defibrillator) These devices are indicated for use as follows:LIFEPAK® 1000 DefibrillatorThe defibrillator is to be used in AED mode only on patients who are in cardiopulmonary arrest. The patient must be unresponsive, not breathing normally, and showing no signs of circulation. The defibrillator may be used with standard defibrillation pads only on adults and children who are 8 years old or more or who weigh more than 25 kg (55 lbs). The defibrillator may be used on children who are less than 8 years old or weigh less than 25 kg (55 lbs) with Infant/Child Reduced Energy Defibrillation Electrodes.LIFEPAK® 20/20e Defibrillator/Monitors The AED mode is to be used only on patients in cardiopulmonary arrest. The patient must be unconscious, pulseless, and not breathing normally before using the defibrillator to analyze the patient’s ECG rhythm. In AED mode, the LIFEPAK® 20 and LIFEPAK® 20e defibrillator/monitor is not intended for use on pediatric patients less than 8 years old. LIFEPAK® 15 Defibrillator/Monitors AED mode is to be used only on patients in cardiopulmonary arrest. The patient must be unconscious, pulseless, and not breathing normally before using the defibrillator to analyze the patients ECG rhythm. In AED mode, the LIFEPAK® 15 monitor/defibrillator is not intended for use on pediatric patients less than 8 years old.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MKJ. The earliest in FDA's data is K853564, decided Oct 11, 1985.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Physio-Control, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

4 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.